Jiangsu Lianhuan Pharmaceutical Co Ltd Class A 600513
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ¥8.87
- Day Range
- ¥8.90–9.63
- 52-Week Range
- ¥6.71–14.40
- Bid/Ask
- ¥9.55 / ¥9.56
- Market Cap
- ¥2.73 Bil
- Volume/Avg
- 15.4 Mil / 4.2 Mil
Key Statistics
- Price/Earnings (Normalized)
- 22.76
- Price/Sales
- 1.16
- Dividend Yield (Trailing)
- 1.57%
- Dividend Yield (Forward)
- 1.57%
- Total Yield
- 1.57%
Company Profile
Jiangsu Lianhuan Pharmaceutical Co Ltd is engaged in producing benign prostatic hyperplasia, allergy and cardiovascular drugs.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- 1,296
- Website
- http://www.lhpharma.com
Comparables
Valuation
Metric
|
600513
|
000739
|
688553
|
---|---|---|---|
Price/Earnings (Normalized) | 22.76 | 20.02 | 60.53 |
Price/Book Value | 1.99 | 3.18 | 1.48 |
Price/Sales | 1.16 | 1.69 | 5.48 |
Price/Cash Flow | 11.21 | 10.59 | 30.81 |
Price/Earnings
600513
000739
688553
Financial Strength
Metric
|
600513
|
000739
|
688553
|
---|---|---|---|
Quick Ratio | 0.56 | 0.97 | 2.65 |
Current Ratio | 0.99 | 1.30 | 2.93 |
Interest Coverage | 8.14 | 35.39 | 12.08 |
Quick Ratio
600513
000739
688553
Profitability
Metric
|
600513
|
000739
|
688553
|
---|---|---|---|
Return on Assets (Normalized) | 4.24% | 7.96% | 1.73% |
Return on Equity (Normalized) | 9.03% | 16.93% | 2.13% |
Return on Invested Capital (Normalized) | 6.41% | 13.55% | 1.32% |
Return on Assets
600513
000739
688553
Drug Manufacturers - Specialty & Generic Industry Comparables
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|---|---|
Zoetis Inc Class A
ZTS
| Cwkqmtcmt | Vgvp | $87.2 Bil | |||
Merck KGaA ADR
MKKGY
| Zsdsnmmmv | Vznqhq | $75.7 Bil | |||
Haleon PLC ADR
HLN
| Bkyxvtxq | Jcvt | $47.3 Bil | |||
Teva Pharmaceutical Industries Ltd ADR
TEVA
| Vtdcxqpqr | Lsfr | $20.0 Bil | |||
Viatris Inc
VTRS
| Yctfqczt | Kyklj | $13.7 Bil | |||
Dr Reddy's Laboratories Ltd ADR
RDY
| Wmlzhlg | Xgh | $13.4 Bil | |||
Catalent Inc
CTLT
| Mxymyfk | Nvwkrpg | $11.0 Bil | |||
Prestige Consumer Healthcare Inc
PBH
| Dwwmphqt | Wmztq | $3.5 Bil | |||
Perrigo Co PLC
PRGO
| Lbdwyysmv | Ycqw | $3.4 Bil | |||
Green Thumb Industries Inc
GTBIF
| Jylmwrmtvs | Vgyxz | $2.4 Bil |